Puma Biotechnology, Inc.
PBYI
$4.98
-$0.275-5.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 48.45M | 38.07M | 30.28M | 23.24M | 8.72M |
| Total Depreciation and Amortization | 11.28M | 11.42M | 11.52M | 11.57M | 11.57M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.87M | 7.48M | 7.73M | 9.17M | 10.34M |
| Change in Net Operating Assets | -22.26M | -25.68M | -10.61M | -10.22M | 2.72M |
| Cash from Operations | 44.34M | 31.28M | 38.92M | 33.77M | 33.34M |
| Capital Expenditure | -117.00K | -117.00K | -56.00K | -85.00K | -92.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.66M | 290.00K | -20.38M | -26.20M | -15.28M |
| Cash from Investing | -11.78M | 173.00K | -20.44M | -26.29M | -15.37M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -44.44M | -44.44M | -33.33M | -22.22M | -11.11M |
| Issuance of Common Stock | 280.00K | 150.00K | 150.00K | 150.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -888.00K | -888.00K | -666.00K | -445.00K | -222.00K |
| Cash from Financing | -45.05M | -45.18M | -33.85M | -22.52M | -11.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.49M | -13.72M | -15.37M | -15.04M | 6.64M |